Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
2019
Background
The limited proliferative ability of hepatocytes is a major limitation to meet their demand for cell-based therapy, bio-artificial liver device, and drug tests. One strategy is to amplify cells at the hepatoblast (HB) stage. However, expansion of HBs with their bipotency preserved is challenging. Most HB expansion methods hardly maintain the bipotency and also lack functional confirmation.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
38
References
3
Citations
NaN
KQI